A medical oncologist from Tulane University co-led the VISION trial, a study focusing on the use of a specific engineered radioactive molecule used to target…
A group of oncology-focused researchers led by co-principal investigator Ashesh B. Jani, MD, professor of radiation oncology at Winship Cancer Institute at Emory University, revealed…
A world-renowned U.S. cancer research center and National Cancer Institute comprehensive cancer center based in the Los Angeles area has launched a Phase 2 clinical…
Pfizer’s Global Medical Grants group awarded a $250,000 grant to the prominent health system in the Detroit metropolitan area, Henry Ford Cancer Institute, to reduce…
One of the biggest challenges facing clinical trial sponsors and investigational sites centers on the efficient identification, recruitment and ongoing retention of sufficient numbers of…
A study from the Winship Cancer Institute of Emory University (Winship) has the potential to change how patients whose prostate cancer recurs after prostatectomy are…
Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an Investigator Initiated Trial (IIT) targeting MRI-Ultrasound fusion guided focal laser ablation treatment…
China’s Hinova Pharmaceuticals closed nearly $146 million in a series C round investment to support multicenter clinical trials and the commercialization of their leading drug…
Piedmont Healthcare is participating in two clinical research trials to study treatments for prostate cancer. One study examines the effects of stereotactic body radiation therapy…
A privately-held Seattle-based biotechnology company secured $1.44 million on the second of a competitive Small Business Innovation Research (SBIR) Phase IIB grant from the National…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
